秒速时时彩

Announcement of the environmental protection acceptance monitoring and acceptance report for the phased completion of the FDA production center project of the new drug formulation supporting raw materials of CSPC (and the second phase of Sino-Nano Relocation and Upgrade Project)

Posted: December 02, 2019 Posted by: CSPC


According to the "Decision of the State Council on Amending the" Regulations on the Management of Environmental Protection of Completion of Construction Projects "(State Council Decree No. 682), the Ministry of Environmental Protection's" Announcement on Promulgation "(National Environmental Regulation and Environmental Assessment [2017] No. 4), and the" Environment of Construction Projects " The requirements for the approval of impact assessment documents and the construction unit ’s independent implementation of environmental protection facility inspection and acceptance guidelines (for trial implementation) (Jihuanbanzihan [2017] No. 727) requirements, now “Stone Pharmaceutical Group Ouyi Pharmaceutical Co., Ltd.” The “Environmental Protection Acceptance Monitoring Report Form for Completion of Pharmaceutical Industrialization Projects” is published as follows:

Project Name: FDA Production Center Project of New Pharmaceutical Preparation Materials for CSPC (and Sino-Nano Relocation and Upgrade Project Phase II) Phase Project

Construction unit: CSPC Ouyi Pharmaceutical Co., Ltd.

Public content: Acceptance report, acceptance opinions, and list of acceptance groups, see the attachment for details: http://pan.baidu.com/s/1vCsweroqM1dwQS4uYcRoBQ Extraction code: pT4Z

Publicity time: 2019.12.2- 2019.12.31

During the publicity period, if you have any objection to the above publicity content, please write back to CSPC Ouyi Pharmaceutical Co., Ltd.

Li Yang, feedback telephone: 0311-87171523

CSPC Ouyi Pharmaceutical Co., Ltd.

December 2, 2019